Catalyst
Slingshot members are tracking this event:
PDUFA 2H 2016 for VIEKIRA PAK - once-daily, fixed-dose formulation for HCV - genotype - through Abbvie
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ENTA | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 25, 2016
Occurred Source:
http://ir.enanta.com/phoenix.zhtml?c=147990&p=irol-newsArticle&ID=2188052
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Hcv, Chronic Hepatitis C Virus, Viekira Pak, Ribavirin, Genotype 1
